Donna R. Cryer, JD, is the founder and Chief Executive Officer of the Global Liver Institute, the only patient-driven liver health nonprofit operating in the US and Europe. For almost a decade Mrs. Cryer founded and led CryerHealth, a healthcare consulting firm providing strategic counsel to top biopharmaceutical companies, patient advocacy organizations, and emerging technology firms on patient engagement in health information technology, drug discovery, and clinical decision making. Mrs. Cryer serves on the Boards of Directors of The Innovation and Value Initiative (IVI), the Sibley Memorial Hospital/Johns Hopkins Medicine, the Executive Committee for the Clinical Trials Transformation Initiative and the Executive Advisory Committee for Tivity Health (NASDAQ: TVTY). She is also a patient representative to the U.S. Food and Drug Administration.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.